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In Tanzania sputum culture for tuberculosis (TB) is resource intensive and available only at zonal facilities. In this study overnight
pooled sputum collection technique was compared with standard spot morning collection among pulmonary TB suspects at
Kibong’otoNationalTBHospitalinTanzania.Aspotsputumspecimenperformedatenrollment,anovernightpooledsputum,and
single morning specimen were collected from 50 subjects and analyzed for quality, quantity, and time to detection in Bactec MGIT
system. Forty-six (92%) subjects’ overnight pooled specimens had a volume ≥5mls compared to 37 (37%) for the combination of
spot and single morning specimens (P<0.001). Median time to detection was 96 hours (IQR 87–131) for the overnight pooled
specimens compared to 110.5 hours (IQR is 137 right 137–180) for the combination of both spot and single morning specimens
(P = 0.001). In our setting of limited TB culture capacity, we recommend a single pooled sputum to maximize yield and speed
time to diagnosis.
1.Background
Tuberculosis (TB) and HIV are among the global leaders in
infectious disease mortality [1]. Sub-Saharan Africa has one
of the highest burdens of TB and HIV coinfection [2].
Prompt diagnosis of TB is critical to improve outcome, but
diagnosis of TB is challenging in HIV-infected patients and
especially in resource-limited settings [3]. HIV-infected pa-
tients have a higher rate of extrapulmonary TB, atypical
chest radiographs and fewer pulmonary cavities [4–6]. As a
consequence, HIV patients may be more likely to have a neg-
ative or paucibacillary sputum smear microscopy [7]. Sub-
jects with paucibacillary specimens may be prone to being
delayed in clinical diagnosis, either because acid-fast bacilli
are not observed by microscopy or time to detection Myco-
bacterium tuberculosis (MTB) culture is prolonged [8]. Both
poor quality and low quantity of sputum have a signiﬁcant
impact on TB detection rate [9, 10]. In settings reliant on
smear microscopy as the only means of TB diagnosis, this
may impact negatively the time to initiation of TB treatment.
Ideal specimens should contain 5mL or more of sputum
without saliva. A previous study found that the quality and
quantity of sputum were improved by pooling three versus a
single“spot”collection[11].However,collectiononmultiple
days may unnecessarily burden health facilities and may
be prone to contamination. In contrast, a single overnight
pooled technique whereby a patient is given a sealable con-
tainer in which to collect all expectorated sputum over the
course of the night has been used in TB treatment trials and
in assessment of early bactericidal activity of new TB medi-
cations [12, 13]. However it has not been examined in rou-
tine clinical practice.
At Kibong’oto National TB Hospital in Kilimanjaro, Tan-
zania,HIVcoinfectionamongTBsuspectsiscommonandit2 Tuberculosis Research and Treatment
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Figure 1: Study diagram of enrollment and specimen analysis.
Table 1: Demographic and clinical characteristics.
Variables (N = 50) Measure
Sex
Male 36 (72%)
Age (years) median (IQR) 38.5 (30–46)
Weight (kg) median (IQR) 51 (47–58)
HIV status
Positive 8 (16%)
CD4 count (cells/µL) by HIV status in
median (IQR)
HIV positive 71 (30.5–158)
HIV negative 540 (409–614)
Chest X-ray ﬁndings
Cavities 23 (46%)
has been observed that the minority of patients have cavitary
chest radiographs. Furthermore it is a standard practice that
each TB suspect is given a sealable mug to collect all sputum
asaninfectioncontrolmeasure.Thus,amongapopulationat
riskforlowerbacillaryyield,wesoughttocompareovernight
pooled sputum in the sealable mugs to the standard spot
technique for sputum quality, quantity, and time to MTB
detection by culture in the Bactec MGIT system, a method
which has correlated well with conventional colony counts
[14, 15].
2. Methods
Subjects suspected of pulmonary TB at Kibong’oto National
TB Hospital were recruited for enrollment. Subjects were
eligible if they were 18 years and above and presenting with
two weeks or more of cough. Each patient was asked to col-
lect three sputum samples in calibrated wide mouthed con-
tainer: (1) a spot specimen at the time of enrollment, (2)
an overnight pooled specimen, and (3) a spot specimen
on the morning after enrollment (Figure 1). Subjects were
excluded if initiated on any antituberculosis medication pri-
or to sample collection. Sputum samples were sent to Kili-
manjaro Clinical Research Institute (KCRI) laboratory for
processing. The specimens were assessed for volume collect-
ed, presence of blood, and color. Samples were analyzed for
qualitybasedonthefollowingcriteria:(1)volumeequaltoor
more than 5mls, (2) sputum color was white, yellow, green,
or red, (3) presence of blood, and (4) thick consistency. Each
sputum specimen was decontaminated with 4% NaOH and
centrifuged at 1500g for 10 minutes. The sediment was split
equally for use in direct smear microscopy by Ziehl-Neelsen
staining, MTB culture on solid agar with Lowenstein-Jen-
sen slant and Middlebrook 7H11 media, and in liquid me-
dia using Bactec MGIT 960 machine (Becton Dickinson,
USA). Positive culture growth was conﬁrmed by secondary
Ziehl-Neelsen stain. Colony-forming unit (CFU) count was
performed on the Middlebrook 7H11 media.
Data were analyzed by Stata Version 11 statistical soft-
ware (StataCorp, U.S.A). Values were presented as means
with standard deviation (SD) or median with interquartile
range (IQR) for data that was not normally distributed. Chi-
square was used for dichotomous variables and Spearman’s
correlation coeﬃcient for continuous variables to investigate
the association with microscopy and culture yield. All tests
were two sided with P values ≤ 0.05 regarded as statistically
signiﬁcant.
All subjects provided written informed consent. Ethical
approval for the study was given by the IRB of the Kiliman-
jaro Christian Medical Center, Tumaini University and the
National Ethical Review Board.
3. Results
Fifty pulmonary TB suspects were enrolled for the study,
eachproducedthreespecimens,hence150sampleswereused
for analysis. The median age of patients was 38.5 years (IQR
30–45) (Table 1). Thirty-six (72%) were male and 8 (16%)Tuberculosis Research and Treatment 3
Table 2: Comparison of overnight pooled and spot method of collection on quality and quantity of sputum.
Measure Combination of spot and single morning
specimen Overnight pooled P value
Quantity (≥5mls) 37/100 (37%) 46/50 (92%) P<0.001
Color 92/100 (92%) 47/50 (94%) P = 0.79
Thick consistency 66/100 (66%) 41/50 (82%) P = 0.12
Presence of blood 11/100 (11%) 6/50 (12%) P>0.99
∗P values are similar if pooled is compared with spot or single morning specimen, thus we combined spot and single for this table.
were HIV-1-infected patients. Among the HIV-infected sub-
jects, the median CD4 count was 71 cells/µL (IQR 30.5–158).
The median CD4 count for HIV-seronegative patients was
540cell/µL (IQR 409–614). Twenty-three (46%) had cavitary
disease (Table 1).
Overnight pooled sputum yielded a specimen of ≥5mL
in46(92%)ofsubjectscomparedto37(37%)forthecombi-
nation of spot and single morning specimens (P<0.001).
Good quality of sputum specimen by color was observed
in 47 (94%) of the patients for overnight pooled sputum—
while combination of spot and single morning specimens
was 92 (92%) (P = 0.79). Thick consistency was observed in
41 (82%) of patients for overnight pooled compared to com-
bination of spot and single morning 66 (66%) (P = 0.12),
and presence of blood was observed in 6 (12%) and 11
(11%), respectively (P>0.99) (Table 2).
Overall 100 (67%) specimens were positive by smear mi-
croscopy.Thirty-four(68%)spotspecimensweresmearpos-
itive, compared to 31 (62%) single morning specimens, and
35(70%)forovernightpooled(P = 0.28).Eighty-one(54%)
culture-positive specimens were available for comparison of
time to detection in the MGIT system from 27 subjects; 49
(33%) specimens were negative and bacterial contamination
precluded analysis in 20 (13%). The MGIT contamination
rate did not diﬀer from that of Lowenstein-Jensen, found in
21 (14%) of all specimens. Furthermore, among MGIT spec-
imens contamination did not vary by method of collection:
spot (5.3%), single morning (3.3%) and overnight pooled
(4.7%) (P>0.99). However, the median time to detection
was 96 hours (IQR 87–131) for the overnight pooled
specimens which was signiﬁcantly faster compared to 118
hours (IQR 98–167) for single morning specimen and 143
hours (IQR 108–194) for the spot specimens (P<0.005)
(Figure 2).
OnlyalimitednumberofpooledspecimenswereTB-cul-
ture positive on Middlebrook 7H11 to allow colony forming
unit (CFU) count determination. The median CFU count
among subjects with cavities on chest radiograph was
4.92log/mL (IQR 4.3–6.28) compared to 3.95log/mL (IQR
3.61–4.84) in patients without cavities (P = 0.12). Among
the 8 HIV-infected subjects, only 2 (25%) had overnight
pooled specimens available for CFU count. The median CFU
count among HIV-infected subjects was 4.34log/mL (IQR
3.9–4.72) compared to 4.84log/mL (IQR 4.30–5.86) for the
HIV-uninfected subjects (P = 0.43). There was no cor-
relation between CD4 counts with CFU (Spearman’s rho =
































tion method. ∗P<0.005 comparing pooled to morning or spot.
4. Discussion
The major ﬁnding of this study was that in routine prac-
tice an overnight pooled sputum collection signiﬁcantly im-
proved the time to detection in the MGIT system among cul-
ture-positive samples. This is an important ﬁnding amidst
the global scale-up of MTB culture.
Faster time to diagnosis in a TB suspect can speed drug
susceptibility testing, hasten proper treatment, and poten-
tially decrease transmission to the community and within
the hospital. In settings with increasing rates of multidrug-
resistant (MDR) TB, faster drug susceptibility results have
been postulated to be one of the most important means of
improving MDR TB outcome [16].
Sputumcollectionistheﬁrstandmostcriticalstepinlab-
oratory diagnosis of pulmonary TB. In resource-limited set-
tings such as ours, multiple specimen collection has been
proposed to increase yield for rapid molecular probe diag-
nostics [17, 18]; however it can be overwhelming to the
laboratory.Bothmicroscopyandculturearetimeconsuming
and culture is costly. In Tanzania culture is recommended for
smear-negative cases, for treatment failures and for monitor-
ing MDR-TB patients. Currently there are few laboratories
capableofcultureandspecimensmustbesentlongdistances.
Inthissetting,maximizingyieldbysendingtheoptimalspec-
imen will conserve resources. We would strongly advocate
sending pooled specimens in our context.
Our ﬁndings of increased culture yield with volumes of a
minimum of 5mls of adequate quality are consistent with
previous studies that examined yield of microscopy [19, 20].4 Tuberculosis Research and Treatment
However, our microscopy yield did not approach the
remarkable >95% rate of smear positivity reported by oth-
ers when a 24-hour collection technique was used for diag-
nosis of selected subjects with pulmonary TB [21]. This is
potentially contributed by the fact that we selected for pul-
monary TB suspects and not conﬁrmed cases. With an eye
towards molecular diagnostics in the future, given the drop
in sensitivity of the rapid molecular diagnostics in smear-
negative sputum samples [17], we would expect that over-
nightpooledsputumcollectionwouldbeequaltoorimprove
upon molecular diagnostic yield compared with a spot spec-
imen.
Our study has several limitations. For the CFU analysis
on the overnight pooled specimens, fungal overgrowth lim-
ited examination of nine diﬀerent plates. The contamination
aﬀected subjects with and without cavities so it is unlikely
to have biased this ﬁnding; yet overall our total number of
patients enrolled was small and may not have included
enough HIV-infected patients to appreciate diﬀerences in
this subgroup with regard to culture yield, CFU analysis, and
time to detection. Bacterial contamination also limited eval-
uation of all samples in the MGIT, but the contamination
was observed in all specimen collection techniques and has
been reported in other evaluations of liquid culture in MGIT
[22]. Furthermore, the culture yield for all techniques may
have been diminished by splitting specimens for both solid
a n dl i q u i dc u l t u r e .
In conclusion, we found that overnight pooled sputum
collection improved the quantity of sputum without altera-
tion in quality and led to faster time to detection. These ﬁnd-
ings can ultimately impact the decisions both of treatment
and infection control. Overnight pooled sputum should be
considered as an alternative to standard spot testing in re-
source-limited settings.
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